XVII CONGRESSO MINEIRO DE PNEUMOLOGIA E CIRURGIA TORÁCICA e VI CONGRESSO MINEIRO DE PNEUMOLOGIA PEDIÁTRICA
1º Dia - 10/10/25
2º Dia - 10/11/25
3º Dia - 10/9/25

Tratamento Oral das TBDR Voltar

Silvana Spindola de Miranda

Mesa Redonda - Micobactérias - Silvana Spindola de Miranda

Artigo Autor(es) Referência
An All-Oral 6-Month Regimen for Multidrug-Resistant TB (the NExT Study): A Multicenter, Randomized Controlled Trial. Esmail Aliasgar, Oelofse Suzette, Lombard Carl, Perumal Rubeshan, Mbuthini Linda, Goolam Mahomed Akhter, Variava Ebrahim, Black John, Oluboyo Patrick, Gwentshu Nelile, Ngam Eric, Ackerman Tertius, Marais Linde, Mottay Lynelle, Meier Stuart, Pooran Anil, Tomasicchio Michele, Te Riele Julian, Derendinger Brigitta, Ndjeka Norbert, Maartens Gary, Warren Robin, Martinson Neil, Dheda Keertan American journal of respiratory and critical care medicine. 2022 Feb; doi: 10.1164/rccm.202107-1779OC. pii: .
Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review. Silva Denise Rossato, Fernandes Flávia Fonseca, Ferreira Juliana Carvalho, Bernando Wanderley, Dalcolmo Margareth Maria Pretti, Johansen Fernanda Dockhorn Costa, Mello Fernanda Carvalho de Queiroz Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2025 ; 50():e20240295. doi: 10.36416/1806-3756/e20240295. pii: S1806-37132024000601500.
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial. Padmapriyadarsini Chandrasekaran, Oswal Vikas S, Jain Chetankumar D, Mariappan Muthu Vijayalakshmi, Singla Neeta, Kumar Santosh, Daniel Bella Devaleenal, Dave Jigna D, Vadgama Parul, Ramraj Balaji, Kant Surya, Bhatnagar Anuj K, Shanmugam Sivakumar, Paul Dhamodharan, Bharathi Jeyadeepa, Palav Manasi, Shah Neha V, Santhanakrishnan Rameshkumar, Dewan Ravindra K, Shekh Nadim, Rathinam Prabhakaran, Sisara Arvind B, Mankar Shubhangi Dhakulkar, Bajpai Jyoti, Mittal Upasana, Chauhan Sandeep, Kumar Ravinder, Parmar Mallik, Mattoo Sanjay K, Jaju Jyoti, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Dec; 79(Dec):1375-1385. doi: 10.1093/cid/ciae388. pii: .
Efficacy and safety data on pretomanid for drug-resistant TB. Thuy H T T, Padmapriyadarsini C, Chuchottaworn C, Foraida S, Hadigal S, Birajdar A R IJTLD open. 2025 Feb; 2(Feb):73-82. doi: 10.5588/ijtldopen.24.0360. pii: .
Impact of all-oral bedaquiline-based shorter regimens in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. Fekadu Ginenus, Tolossa Tadesse, Bekele Firomsa, Chen Xiaohan, He Yan, Yu Jing, Yi Xinyao, Liu Ming, Fetensa Getahun, Dugassa Dinka, Turi Ebisa, Feyissa Tesfaye Regassa, Chaiyakunapruk Nathorn, Yang Lianping, Chen Shanquan, Ming Wai-Kit BMJ global health. 2025 Apr; 10(Apr):doi: 10.1136/bmjgh-2024-018220. pii: e018220.
Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis. Shah Ira, Poojari Vishrutha, Meshram Himali Indian journal of pediatrics. 2020 Feb; doi: 10.1007/s12098-020-03230-1. pii: .
Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States. Haley Connie A, Macias Patricia, Jasuja Supriya, Jones Betsy A, Rowlinson Marie-Claire, Jaimon Roshni, Onderko Pennelyn, Darnall Elaine, Gomez Maria E, Peloquin Charles, Ashkin David, Goswami Neela D Emerging infectious diseases. 2020 Nov; 27(Nov):doi: 10.3201/eid2701.203766. pii: .
Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis. Kwak Nakwon, Kim Joong-Yub, Han Areum, Berry Catherine, Beumont Maria, Tweed Conor, Crook Angela, Dheda Keertan, Fabiane Stella, Fadeyi Muse O, Foraida Salah, Gils Tinne, Hoang Thi Thanh Thuy, Jham Menal A, Murphy Richard A, Nguyen Binh Hoa, Nguyen Thi Mai Phuong, Nyang'wa Bern Thomas, Oelofse Suzette, Hahn Seokyung, Yim Jae-Joon The European respiratory journal. 2025 Aug; 66(Aug):doi: 10.1183/13993003.00315-2025. pii: 2500315.
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis. Guglielmetti Lorenzo, Khan Uzma, Velásquez Gustavo E, Gouillou Maelenn, Abubakirov Amanzhan, Baudin Elisabeth, Berikova Elmira, Berry Catherine, Bonnet Maryline, Cellamare Matteo, Chavan Vijay, Cox Vivian, Dakenova Zhanna, de Jong Bouke Catherine, Ferlazzo Gabriella, Karabayev Aydarkhan, Kirakosyan Ohanna, Kiria Nana, Kunda Mikanda, Lachenal Nathalie, Lecca Leonid, McIlleron Helen, Motta Ilaria, Toscano Sergio Mucching, Mushtaque Hebah, Nahid Payam, Oyewusi Lawrence, Panda Samiran, Patil Sandip, Phillips Patrick P J, Ruiz Jimena, Salahuddin Naseem, Garavito Epifanio Sanchez, Seung Kwonjune J, Ticona Eduardo, Trippa Lorenzo, Vasquez Dante E Vargas, Wasserman Sean, Rich Michael L, Varaine Francis, Mitnick Carole D, The New England journal of medicine. 2025 Jan; 392(Jan):468-482. doi: 10.1056/NEJMoa2400327. pii: .
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications. Rich M L, Khan U, Zeng C, LaHood A, Franke M F, Atwood S, Bastard M, Burhan E, Danielyan N, Dzhazibekova P M, Gadissa D, Ghafoor A, Hewison C, Islam M S, Kazmi E, Khan P Y, Lecca L, Maama L B, Melikyan N, Naing Y Y, Philippe K, Saki N A, Seung K J, Skrahina A, Tefera G B, Varaine F, Vilbrun S C, Võ L, Mitnick C D, Huerga H The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2023 Jun; 27(Jun):451-457. doi: 10.5588/ijtld.22.0613. pii: .
Treatment of Drug-Resistant Tuberculosis. Mase Sundari R, Chorba Terence Clinics in chest medicine. 2019 Dec; 40(Dec):775-795. doi: 10.1016/j.ccm.2019.08.002. pii: S0272-5231(19)30066-8.
Update of drug-resistant tuberculosis treatment guidelines: A turning point. Vanino Elisa, Granozzi Bianca, Akkerman Onno W, Munoz-Torrico Marcela, Palmieri Fabrizio, Seaworth Barbara, Tiberi Simon, Tadolini Marina International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2023 May; 130 Suppl 1(May):S12-S15. doi: 10.1016/j.ijid.2023.03.013. pii: S1201-9712(23)00089-9.
[Treatment of drug-resistant tuberculosis in adults and children. A narrative review]. Palmero Domingo J, Lagrutta Laura, Inwentarz Sandra J, Vescovo Marisa, Aidar Omar J, González Montaner Pablo J Medicina. 2022 ; 82():117-129.
Nenhuma revista foi definida para este congresso.